Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS).
Yoshida
Y
Y
Department of Medicine, Faculty of Medicine, Kyoto University, Japan.
Asano
S
S
Hirashima
K
K
Takaku
F
F
D000741:Anemia, Aplastic / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy*; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D016037:Single-Blind Method
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor